中华内科杂志最新文献

筛选
英文 中文
[A case of subacute phosphate nephropathy caused by oral sodium phosphate]. [一例由口服磷酸钠引起的亚急性磷酸盐肾病]。
中华内科杂志 Pub Date : 2024-10-01 DOI: 10.3760/cma.j.cn112138-20240412-00237
B F Su, S S Lin, Y Liang, B Chen, C S Chen
{"title":"[A case of subacute phosphate nephropathy caused by oral sodium phosphate].","authors":"B F Su, S S Lin, Y Liang, B Chen, C S Chen","doi":"10.3760/cma.j.cn112138-20240412-00237","DOIUrl":"10.3760/cma.j.cn112138-20240412-00237","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 10","pages":"1007-1010"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on the pathogenesis of acquired aplastic anemia]. [获得性再生障碍性贫血发病机制研究进展]。
中华内科杂志 Pub Date : 2024-10-01 DOI: 10.3760/cma.j.cn112138-20240411-00233
H Yu, Y Y Lei, S X Ding, R Fu
{"title":"[Research progress on the pathogenesis of acquired aplastic anemia].","authors":"H Yu, Y Y Lei, S X Ding, R Fu","doi":"10.3760/cma.j.cn112138-20240411-00233","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20240411-00233","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 10","pages":"1024-1028"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Report of six cases with mast cell leukemia and a literature review]. [六例肥大细胞白血病病例报告及文献综述]。
中华内科杂志 Pub Date : 2024-10-01 DOI: 10.3760/cma.j.cn112138-20240401-00209
F Zhu, Y Yu, C Y Chen, W B Duan, Q Jiang, R Yan, Y Sun, Y Q Han, J Zhang, H Wang, Q R Zhang, S N Chen, W H Yan, M J Cai, Z B Zhang, J Yin, Q Wang
{"title":"[Report of six cases with mast cell leukemia and a literature review].","authors":"F Zhu, Y Yu, C Y Chen, W B Duan, Q Jiang, R Yan, Y Sun, Y Q Han, J Zhang, H Wang, Q R Zhang, S N Chen, W H Yan, M J Cai, Z B Zhang, J Yin, Q Wang","doi":"10.3760/cma.j.cn112138-20240401-00209","DOIUrl":"10.3760/cma.j.cn112138-20240401-00209","url":null,"abstract":"<p><p>From October 2021 to February 2023, we retrospectively analyzed the clinical and laboratory data of six patients (three male and three female, median age: 54 years, age range: 29-73 years) with mast cell leukemia (MCL) diagnosed in the First Affiliated Hospital of Soochow University (The Mastocytosis Collaborative Network of China). All patients had acute MCL, with at least one C-finding present. The main clinical presentations were hypoalbuminemia (<i>n</i>=4), fatigue (<i>n</i>=3), fever (<i>n</i>=2), abdominal discomfort (<i>n</i>=2), osteolytic lesions (<i>n</i>=2), dizziness (<i>n</i>=1), skin flushing (<i>n</i>=1), and weight loss (<i>n</i>=1). Splenomegaly and lymphadenopathy were noted in six and three patients, respectively. Six patients were strongly positive for CD117, five were positive for CD30 and CD25, and four were positive for CD2. Four patients had a normal karyotype and two patients had an abnormal karyotype. Gene mutations were detected in 4/6 cases. The median serum tryptase level was 24.9 (range: 20.1-171.9) μg/L. Two patients were treated with venetoclax and azacitidine for induction (one patient achieved partial remission by combination with afatinib, while there was no remission after combination with dasatinib in the other patient). Two patients did not achieve complete remission despite treatment with cladribine and imatinib, respectively. One patient treated with interferon combined with glucocorticoids was lost to follow-up, and one patient abandoned treatment. The follow-up time ranged from 1.1 to 21.7 months. Three patients died and two survived. Overall, MCL is a rare subtype of systemic mastocytosis with heterogeneous clinical course, and these patients have poor outcome. A better understanding of the clinical characteristics, treatment, and prognosis of MCL is urgently needed.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 10","pages":"996-1000"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Study on the correlation between fatty liver index and the outcome of high normal blood pressure]. [脂肪肝指数与正常高血压结果的相关性研究]。
中华内科杂志 Pub Date : 2024-10-01 DOI: 10.3760/cma.j.cn112138-20240409-00229
J C Qu, A P Wang, J T Dou, W J Gu, Z H Lyu, Y M Mu
{"title":"[Study on the correlation between fatty liver index and the outcome of high normal blood pressure].","authors":"J C Qu, A P Wang, J T Dou, W J Gu, Z H Lyu, Y M Mu","doi":"10.3760/cma.j.cn112138-20240409-00229","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20240409-00229","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the correlation between fatty liver index (FLI) and the outcomes of individuals with high normal blood pressure. <b>Methods:</b> In this retrospective cohort study, data from the follow-up population of the Beijing branch of the Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal (REACTION) study conducted from December 2011 to August 2012 were selected. Obtain indicators such as height, weight, waist circumference, fasting blood glucose, 2-h postprandial blood glucose, triglycerides, high-density lipoprotein cholesterol, and glutamyl transpeptidase were measured, and the FLI was calculated. The population with high normal blood pressure was divided into the FLI<30 group (1 822 cases); 30≤FLI<60 group (1 026 cases); and FLI≥60 group (473 cases) based on FLI levels. The blood pressure outcome data from the follow-up survey of this population from April 2015 to September 2015 were collected. Single factor analysis of variance was used for intergroup comparison, and logistic regression was used to analyze the correlation between FLI and the outcome of high normal blood pressure in the population. <b>Results:</b> The FLI was an independent influencing factor for their conversion to normal blood pressure (all <i>P<</i>0.01). Among all observed populations, the likelihood of conversion to normal blood pressure in the 30≤FLI<60 group and FLI≥60 group was 0.63 (95%<i>CI</i> 0.51-0.78) and 0.61 (95%<i>CI</i> 0.45-0.82) of the FLI<30 group, respectively. In the population of 40≤age<60 years, this likelihood was 0.60 (95%<i>CI</i> 0.47-0.76) and 0.57 (95%<i>CI</i> 0.41-0.79), respectively. FLI is not an independent influencing factor for the conversion to normal blood pressure in individuals aged over 60 years (<i>P</i>=0.161). FLI is an independent risk factor for hypertension (all <i>P</i><0.05). Among all observed populations and population of 40≤age<60 years and age>60 years, the risk of hypertension in the 30≤FLI<60 group and FLI≥60 group was 1.49 times (95%<i>CI</i> 1.23-1.80) and 1.54 times (95%<i>CI</i> 1.19-1.98); 1.41 times (95%<i>CI</i> 1.13-1.75) and 1.38 times (95%<i>CI</i> 1.04-1.83); and 1.75 times (95%<i>CI</i> 1.22-2.53) and 2.10 times (95%<i>CI</i> 1.24-3.58) of the FLI<30 group, respectively. <b>Conclusions:</b> There is a correlation between FLI levels and future outcomes of individuals with normal high blood pressure. Although people with higher FLI are more likely to develop hypertension, those with higher FLI are also less likely to develop normal blood pressure in the 40≤age<60-year group.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 10","pages":"968-974"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Progresses and hot spots of cerebrovascular disease in the past decade]. [过去十年脑血管疾病的进展与热点]。
中华内科杂志 Pub Date : 2024-10-01 DOI: 10.3760/cma.j.cn112138-20240531-00354
J J Li, Y J Wang
{"title":"[Progresses and hot spots of cerebrovascular disease in the past decade].","authors":"J J Li, Y J Wang","doi":"10.3760/cma.j.cn112138-20240531-00354","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20240531-00354","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 10","pages":"917-921"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Atrial fibrillation as initial manifestation in one patient with Fabry disease receiving amiodarone]. [一名法布里病患者在接受胺碘酮治疗后出现心房颤动的初期表现]。
中华内科杂志 Pub Date : 2024-09-01 DOI: 10.3760/cma.j.cn112138-20240326-00195
S J Chen, H Yan, Z H Yu
{"title":"[Atrial fibrillation as initial manifestation in one patient with Fabry disease receiving amiodarone].","authors":"S J Chen, H Yan, Z H Yu","doi":"10.3760/cma.j.cn112138-20240326-00195","DOIUrl":"10.3760/cma.j.cn112138-20240326-00195","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 9","pages":"881-885"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A trend to screen primary aldosteronism not interfering the administration of common antihypertensive drugs]. [筛查原发性醛固酮增多症的趋势不会干扰常用降压药的使用]。
中华内科杂志 Pub Date : 2024-09-01 DOI: 10.3760/cma.j.cn112138-20240110-00024
Y Jing, J B Hu, S M Yang, Y Song, Q F Li
{"title":"[A trend to screen primary aldosteronism not interfering the administration of common antihypertensive drugs].","authors":"Y Jing, J B Hu, S M Yang, Y Song, Q F Li","doi":"10.3760/cma.j.cn112138-20240110-00024","DOIUrl":"10.3760/cma.j.cn112138-20240110-00024","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 9","pages":"835-838"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on clinical features and pathogenesis of anti-gp210-positive primary biliary cholangitis]. [抗gp210阳性原发性胆汁性胆管炎的临床特征和发病机制研究进展]。
中华内科杂志 Pub Date : 2024-09-01 DOI: 10.3760/cma.j.cn112138-20230901-00104
Z Yang, X Y Wang, Y Ran, L Li, B M Wang, L Zhou
{"title":"[Research progress on clinical features and pathogenesis of anti-gp210-positive primary biliary cholangitis].","authors":"Z Yang, X Y Wang, Y Ran, L Li, B M Wang, L Zhou","doi":"10.3760/cma.j.cn112138-20230901-00104","DOIUrl":"10.3760/cma.j.cn112138-20230901-00104","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 9","pages":"901-906"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Two cases of inflammatory myopathy complicated with primary biliary cholangitis with myocardial involvement as the initial manifestation]. [两例并发原发性胆汁性胆管炎的炎症性肌病,心肌受累为最初表现]。
中华内科杂志 Pub Date : 2024-09-01 DOI: 10.3760/cma.j.cn112138-20231206-00366
J Li, Y Y Pang, B W Zhang, S Zhou, Q Wang, J Z Lai, M T Li
{"title":"[Two cases of inflammatory myopathy complicated with primary biliary cholangitis with myocardial involvement as the initial manifestation].","authors":"J Li, Y Y Pang, B W Zhang, S Zhou, Q Wang, J Z Lai, M T Li","doi":"10.3760/cma.j.cn112138-20231206-00366","DOIUrl":"10.3760/cma.j.cn112138-20231206-00366","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 9","pages":"876-880"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Diagnosis and treatment of late onset Pompe disease: a case report]. [晚发型庞贝氏症的诊断和治疗:病例报告]。
中华内科杂志 Pub Date : 2024-09-01 DOI: 10.3760/cma.j.cn112138-20240408-00221
L L Zhou, Y Q Shao, P Xia, X Q Wu, Q Y Chen, Q L Xu
{"title":"[Diagnosis and treatment of late onset Pompe disease: a case report].","authors":"L L Zhou, Y Q Shao, P Xia, X Q Wu, Q Y Chen, Q L Xu","doi":"10.3760/cma.j.cn112138-20240408-00221","DOIUrl":"10.3760/cma.j.cn112138-20240408-00221","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"63 9","pages":"886-888"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信